Other therapeutic targets

Other research in this area includes targeting downstream effectors such as Gli, Hedgehog ligands, generating antibodies to Patched (PTCH) with the intent of blocking Hedgehog binding, and the creation of decoy receptors that would titrate Hedgehog away from PTCH.⁷